(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

FERAHEME FERUMOXYTOL INJECTION

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: Estados Unidos

Snapshot rápido

FERAHEME FERUMOXYTOL INJECTION

ST13

US500000085968862

Classe

5

Pedido

85968862

Registro

4509702

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

55

Atualização mais recente

05/06/2025

Tipo de marca

Mista

Classes Nice

5

Data de depósito

25/06/2013

Data de registro

08/04/2014

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

01/07/2024

Última transação

05/06/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Primeiro uso

14/07/2009

Primeiro uso no comércio

14/07/2009

Código do desenho

3

Tipo de titular

16

Localização do titular

ZUG, CH

Examinador

HAYES, GINA

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the terms "FERAHEME", "FERUMOXYTOL", and "INJECTION" in stylized font, and an oval surrounded in part by another oval. The term "FERAHEME" is located above the term "FERUMOXYTOL", which in turn is located above the term "INJECTION". The ovals are located to the right of the terms "FERUMOXYTOL" and "INJECTION", and below the term "FERAHEME".

Titulares e representantes

Titulares

COVIS PHARMA GMBH
AMAG Pharmaceuticals, Inc.

Representantes

Laura K. Pitts Buchanan Ingersoll & Rooney PC

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparationsferumoxytol for the treatment of hematological diseases and conditions

Publicações

Histórico de despachos e eventos da marca no USPTO.

55 publicações encontradas

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/06/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/04/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/07/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/07/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/07/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/07/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

02/04/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/04/2023

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

23/06/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

19/05/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/02/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

17/02/2021

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

17/02/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

17/02/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

17/02/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

17/02/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/02/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/02/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/02/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/02/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/02/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/05/2020

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/05/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/05/2020

E815

TEAS SECTION 8 & 15 RECEIVED

16/03/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/04/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

19/07/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

08/04/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

21/01/2014

PUBO

PUBLISHED FOR OPPOSITION

21/01/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/01/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

16/12/2013

ALIE

ASSIGNED TO LIE

12/12/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/12/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

10/12/2013

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/12/2013

GNEA

EXAMINERS AMENDMENT E-MAILED

10/12/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/12/2013

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/12/2013

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/12/2013

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

09/12/2013

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

17/11/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/11/2013

ALIE

ASSIGNED TO LIE

30/10/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

15/10/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/10/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/10/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/10/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/10/2013

GNRT

NON-FINAL ACTION E-MAILED

07/10/2013

CNRT

NON-FINAL ACTION WRITTEN

07/10/2013

DOCK

ASSIGNED TO EXAMINER

04/10/2013

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/07/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/07/2013

NWAP

NEW APPLICATION ENTERED

28/06/2013

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace FERAHEME FERUMOXYTOL INJECTION ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.